The spatiotemporally and quantitatively correct activity of a gene requires the presence of intact coding sequence as well as properly functioning regulatory control. One of the great challenges of the post-genome era is to gain a better understanding of the mechanisms of gene control. Proper gene regulation depends not only on the required transcription factors and associated complexes being present (in the correct dosage), but also on the integrity, chromatin conformation and nuclear positioning of the gene's chromosomal segment. Thus, when either the cist rans regulatory system of a gene or the normal context of its chromatin structure are disrupted, gene expression may be adversely affected, potentially leading to disease. As transcriptional regulation is a highly complex process depending on many factors, there are many different mechanisms that can cause aberrant gene expression. Traditionally, the term 'position effect' was used to refer to situations where the level of expression of a gene is deleteriously affected by an alteration in its chromosomal environment, while maintaining an intact transcription unit. Over the past years, an ever increasing number of such disease-related position effect cases have come to light, and detailed studies have revealed insight into the variety of causes, which can be categorized into a number of different mechanistic groups. We suggest replacing the outdated term of 'position effect disease' with the new generic name of 'cis-ruption disorder' to describe genetic disease cases that are caused by disruption of the normal cisregulatory architecture of the disease gene locus. Here, we review these various cis-ruption mechanisms and discuss how their studies have contributed to our understanding of long-range gene regulation.
INTRODUCTION
It is now over half a century since the elucidation of the genetic code. That milestone in the history of molecular biology was reached only a short few years after the discovery of the double helical structure of DNA. The genetic code is a cipher based on the linear order of base triplets in the DNA that dictates which amino acids are incorporated in a growing peptide chain and in what order, to generate the various proteins in an organism. It arguably remains, at least at present, the most relevant code in our genome from a medical viewpoint. The beautiful simplicity of the code makes it easy to identify mutations that will result in a (deleteriously) altered protein. It has enabled large advances in determining the genetic basis of many human genetic diseases. Specific clinical phenotypes have been linked with mutations in an impressive number of genes [1, 2] . More recently, however, it has also become clear that apart from deleterious mutations in the protein encoding part of a gene, genetic disease can equally be caused by disruption of the regulatory mechanisms that ensure its proper expression [3] . The instructions required to produce a gene product in the proper time and place and in the correct quantity are also encoded in our genome and this information is often referred to as the regulatory code. Despite enormous progress in studying mechanisms of gene regulation we are still a long way of from understanding the regulatory code in the same predictive way that we can read the genetic code. This is largely due to the complexity of transcription control, with chromatin structure, epigenetic modifications and combinatorial binding of trans-acting factors to promoters and cis-regulatory elements all playing a role [4] . Detailed study of a number of specific human genetic malformations has been instrumental in revealing the variety of mechanisms by which normal gene regulatory function can be disrupted.
GENETIC DISEASE DUE TO ABERRANT GENE TRANSCRIPTION CAN BE CAUSED BY MANY DIFFERENT MECHANISMS
Disease situations where the expression level of a gene is deleteriously affected by a change in its chromosomal environment, but leaving its transcription unit intact, are traditionally referred to by the term 'position effect'. In recent years, many more such disease cases have been identified, and detailed studies have revealed insight into their molecular aetiology. In light of this increased knowledge, the name 'position effect' seems no longer adequate to cover the variety of mechanisms underlying these disorders. We suggest replacing the term 'position effect mechanisms' with 'cis-ruption mechanisms' as a new generic name to describe the causes of genetic disorders caused by disruption of the normal cisregulatory architecture of the disease gene locus.
Transcription is a highly complex and intricately controlled process that can be disrupted through many different mechanisms. In any particular disease situation, the exact mechanism depends to a large degree on the genomic architecture of the disease gene locus, and different mechanisms acting on the same gene can give rise to different phenotypes. In this review, we aim to categorize the various mechanisms causing disruption of long range cis-regulation that have been encountered in actual disease cases ( Figure 1 ). These scenarios include: (i) deletion of long range cis-elements, (ii) separation of cisregulatory elements from the gene promoters through chromosomal translocations or inversions, (iii) deleterious mutations in cis-elements, (iv) disruption of the normal interactions between promoters and cis-acting enhancers through appearance of a new promoter, (v) alteration of local chromatin structure through interference by aberrant readthrough transcripts, (vi) disturbance of regional chromatin structure, (vii) duplication of a cis-regulatory region, (viii) acquisition of inappropriate tissuespecific upstream promoters or enhancers.
Most of the mechanisms involve the removal or mutation of a long-range cis-regulatory element or disruption of its communication with the promoter. Genetic research commonly applies the study of mutant phenotypes caused by molecular disruptions to infer the function of the disrupted entity in the normal situation. In this way, the study of human genetic disease and particularly of cis-ruption cases provides a valuable and powerful resource for the discovery of new insights into the architecture of the regulatory genome. The worldwide human population forms a large pool of potential subjects for classical genetics that will self-certify, most presenting somewhere at a clinic when affected by a genetic disease. Furthermore, human disease pathology is far better recognized and studied than that of any model organism, and subtle and/or late onset phenotypes are more readily detected in humans. However, two problems arise when a cis-ruption mechanism rather than a coding region mutation is suspected. The first is how to identify and locate the position and extent of the exact molecular lesion. Novel micro-array based and next-generation sequencing methods have made this process much more feasible in recent years [5, 130] . The second obstacle is the problem of how to assess the functional consequence of a mutation/variation in a putative regulatory sequence, and currently there is no simple solution. The genetic code allows variation in protein-coding sequence to be grouped into synonymous and nonsynonymous changes (though it must be kept in mind that even the synonymous changes can be functionally relevant through interference with splicing or RNA stability [6] ). However, the functional consequence of a regulatory variant is far less obvious from the change in sequence alone. Even though disruption of a transcription factor binding site can sometimes be inferred, the exact sequence requirements are often flexible and context dependent. Thus functional assays are essential, but often these use or create highly artificial situations that fail to accurately reflect the endogenous genomic situation. A pressing problem in many cases is the lack of availability of the relevant tissues for study. The possibility of creating iPS cells (induced pluripotent stem cells) from non-invasively obtainable patient tissue followed by directed differentiation towards an appropriate tissue type may hold promise for the future, though it would still fall short in modelling complex developmental processes such as cell interactions and migration [7] . In addition, correct genomic context, chromatin structure, presence of cooperating cis-elements, appropriate target promoter, copy-number, presence of the relevant trans-acting factors and many more variables can all have an influence and will require putative regulatory variants to be tested under a wide range of conditions, preferentially tailored to the specific situation. High-throughput, standardized methods are likely to miss or incorrectly assign functional significance to many variants. Until we have a much better understanding of the 'regulatory code' this is likely to remain problematic.
Despite these drawbacks, an increased awareness of the importance of non-protein-coding sequences in disease coupled with the availability of complete genome sequence for human and many other species, and new genomic technologies has contributed to a rapid growth of the list of cis-ruption disease cases. To introduce some structure into the list, we have attempted to group the cases into distinct mechanistic categories. It is noteworthy that using such classification some genes and diseases may be represented in more than one category (Table 1 ). Each mechanism is described below with one or more actual disease cases as examples.
Deletion of a long-range cis-regulatory element
Loss of a cis-regulatory element through a deletion outside of the transcription unit of a gene is the most obvious mechanism that can create a cis-ruption disease situation. Mostly this entails the removal of one or more positive acting cis-elements, but could also result from loss of repressor or insulator elements. In theory, the loss of cis-elements can lead to disease in both homozygous (recessive) and heterozygous (semi-dominant) states, though in practise most cases are the result of haploinsufficiency of the target gene, for reasons of the low likelihood of a homozygous deletion occurring and the observation Some genes may appear in more than one category in the table, either through causing the same disease by different mechanisms (e.g. -globin and -thalassaemia) or by being involved in different malformations through different mechanisms (e.g. SOX9 and campomelic dysplasia/Pierre Robin Sequence).
that the group of developmental regulator genes, which often display dosage sensitivity, is a prime candidate to be affected by cis-ruption mechanisms. Nevertheless, recessive cases do exist as the example below illustrates.
Van buchem disease
Bone mineral density (BMD), a quantitative trait with relevance for bone fragility and osteoporosis, is associated with several genetic loci, including the SOST locus on 17q21 [8] . Homozygous null mutations in SOST, a known negative regulator of bone formation, cause the severe bone overgrowth malformation sclerosteosis (OMIM 269500) [9, 10] . The phenotypically less severe disorder of Van Buchem disease, a recessive sclerosing bone dysplasia (OMIM293100; [11, 12] ) maps to the same genomic region. Van Buchem patients have an intact SOST coding region but carry a homozygous 52 kb deletion starting 35 kb downstream of the SOST polyadenylation signal and 10 kb upstream of the neighbouring MEOX1 gene [12, 13] . A BAC with the intact human SOST locus faithfully reproduced the endogenous SOST expression pattern in transgenic mice, but had dramatically reduced levels of human SOST mRNA expression when engineered to contain the 52 kb deletion [14] . Two out of three SNPs associated with BMD are located in the Van Buchem deleted region, but the actual causal variant remains to be identified [8] . Using multi-species sequence comparison a possible candidate ciselement was shown to drive expression in the skeleton of E14.5 transgenic mice [14] .
Separation Of Cis-Regulatory Elements From The Gene Promoters Through Chromosomal Translocations Or Inversions
Currently, the most prevalent of recognized cisruption disease cases are those where a chromosomal translocation or inversion has moved part of a gene locus away from the transcription unit, positioning putative essential cis-elements out of reach of their target gene promoter. Most common are again the removal of an enhancer or repressor, but the translocation/inversion could potentially also remove a chromatin insulator. This mechanism is highlighted by a substantial number of aniridia patients with two intact PAX6 coding units.
Aniridia and PAX6
The congenital eye malformation aniridia (OMIM 106210) is the paradigm for cis-ruption diseases. Aniridia is caused by PAX6 haploinsufficiency as shown by point mutation and deletion cases [15, 16] . In the mouse, Pax6 heterozygosity causes the smalleye (Sey) phenotype. A number of aniridia patients with translocation breakpoints mapping downstream of the PAX6 gene have been described [17] [18] [19] . Detailed mapping of these breakpoints placed them at various positions downstream from an intact PAX6 coding region, with the furthest located 125 kb beyond the final exon [17] inside the final intron of a ubiquitously expressed gene, ELP4 (a subunit of Elongator, a protein complex associated with elongating RNA polymerase II).
It was found that a 420 kb human PAX6 YAC, with sequence extending 80 kb beyond the position of the most distal patient breakpoint was able to rescue Sey mice [20] . In contrast, a shorter YAC extending only as far as the breakpoint completely failed to rescue [21] . Essential regulatory elements were identified in the interval between the ends of the YACs using DNaseI hypersensitive site mapping, and reporter transgenic mice revealed eye and brain specific elements, providing strong evidence that the PAX6 cis-ruption effect is due to the removal of these elements, collectively termed the DRR (downstream regulatory region) [21] . To obtain direct evidence that removal of the DRR would lead to loss of PAX6 expression YAC transgenic mice were engineered in which a GFP reporter gene was inserted into the PAX6 coding region and LoxP sites were placed around a 30 kb DRR region. Strong GFP signal was observed in a proper PAX6 expression pattern in full-length YAC transgenics, but after Cre mediated deletion of the DRR expression was no longer found in the neuroretina, iris and ciliary body. As multiple enhancers for these expression sites have been identified, not only within the DRR, but also in upstream and intronic regions of the PAX6 locus, this study not only demonstrates the essential nature of enhancers in the DRR, it also highlights the interdependence of multiple ciselements spread throughout the gene locus [22] . Currently, the phenotype in molecularly defined cases of aniridia caused by a cis-ruption mechanism is indistinguishable from that caused by loss of function coding region mutation or gene deletion. However, in analogy with other situations where different diseases are linked to the same gene, e.g. SOX9 or SHH (see below), there is a strong possibility that variant phenotypes may be linked to disruptions of particular PAX6 cis-elements. Linkage to the PAX6 locus has been found for diseases such as high myopia and epilepsy [23, 24] . All aniridia causing translocations found so far disrupt the downstream regulatory region, indicating the majority of regulatory requirements for eye development are located in that region. Recently, however, a patient with a complex phenotype and a large deletion encompassing many genes, but with one breakpoint between 50 and 150 kb upstream of PAX6 was described. Among the disease features, most of which can be explained by genes in the deletion interval, were ptosis and cataracts, suggesting they may be due to PAX6 misregulation [25] .
Deleterious (point) mutations in a long-range cis-element
Despite the clear importance of long-range regulatory elements for proper development and health, very few examples are known where point mutations or small insertion/deletions in cis-elements are the proven underlying cause of the disease. Enhancers and repressors may be robust and able to tolerate such minor insults to their integrity, especially as they often contain multiple binding sites for specific factors. The relative dearth of regulatory mutants in ENU mutagenesis screens seems consistent with this notion, though this may also be due to more subtle phenotypes going unrecognised in such screens. It is however in contradiction to their often very high levels of evolutionary sequence conservation and the reported absence of validated SNPs in those regions [26] . Due to increased awareness and efforts at identification, more disease cases with mutations in cis-elements are starting to be found. A SNP disrupting an AP2 binding site in an enhancer for IRF6 was shown to increase risk for cleft lip/palate [27] and a point mutation in a putative MSX1 binding site in an enhancer far upstream of SOX9 is associated with Pierre Robin Sequence [28] . A mutation in a SIX3 binding site in a brain-specific enhancer for Sonic Hedgehog (SHH) was found in a patient with holoprosencephaly (HPE) [29] . While HPE is the phenotype caused by SHH haploinsufficiency during early craniofacial and forebrain development, through intragenic mutations [30] or translocations up to 275 kb from the gene [31] , mutations in a limb-specific long range enhancer that result in ectopic gain of SHH expression in the anterior limb bud lead to a different phenotype, the limb malformation pre-axial polydactyly (PPD OMIM 174500) [32] .
Pre-axial polydactyly and SHH misregulation Through analysis of several mouse limb mutants [32] [33] [34] and human pre-axial polydactyly (PPD) patients [35] a small, highly conserved region, termed the ZRS [Zone of polarising activity (ZPA) Regulatory Sequence], was identified 1 Mb upstream of the SHH gene and shown to act as a limb specific regulatory element in transgenic reporter mice [36] . The ZRS, located beyond an adjacent gene, in an intron of a further gene, is thought to have a dual function in the regulation of SHH: first, to drive initiation of expression in the limb bud and secondly to restrict this expression to the posterior margin. Sequencing of the element in a large number of affected and unaffected PPD family members as well as controls revealed single point mutations in the ZRS in four PPD families, which were observed in all affected and none of the unaffected individuals. Single base pair changes segregating with the phenotype were also found in the Hx mouse [36] , in a number of ENU induced mouse mutants [34, 37] and in other PPD families [38] . Expression studies using ZRS sequences to drive reporter expression [37, 40] demonstrate the mutations affect the posterior restricting activity of the ZRS, and lead to ectopic anterior SHH expression, which in turn causes the PPD phenotype. The mutations are found scattered throughout the ZRS, suggesting the phenotype does not simply arise from the inactivation of a single transcription factor binding site. Recent work has shed some light on the mechanism of SHH regulation in the ZPA [41] . Both 3C (chromosome conformation capture) and 3D-FISH suggest a close interaction between the ZRS and SHH coding region/promoter in the expressing posterior limb bud, but also in the anterior limb bud, possibly indicating competence for expression in those cells. Interestingly, the looping was still observed in ZRS knock-out ZPA cells, indicating that other sequences near the ZRS are involved. However, the frequency of looping-out of its chromosome territory (CT) that is observed for the SHH chromosomal segment in wild-type ZPA cells is drastically reduced in mutant ZPA cells as well as in anterior limb bud. Furthermore, it appears that SHH transcription occurs in bursts of activity that correlate with the physical interaction between the ZRS and promoter. Thus, sequences near the ZRS may promote looping between the ZRS region and the promoter, creating a poised state, from which the ZRS appears to promote looping out from the CT and active transcription [41] . Exactly how mutations in the element affect this process remains unresolved at present.
Alteration of local chromatin structure through interference by an antisense transcript
The -globin gene cluster depends on long range control elements for its expression, and deletions removing these elements from the locus, in particular the highly conserved HS-40, are a cause of -thalassaemia [42, 43] . A novel cis-ruption mechanism was revealed in a particular -thalassaemia case of a Polish family carrying an 18 kb deletion, encompassing the HBA1 and HBQ1 genes [44] , but leaving the control elements and HBA2 gene intact. In normal individuals, -globin is produced from both HBA1 and HBA2 genes on chromosome 16. Even though one copy of HBA1 was indeed deleted in this family, the severity of the phenotype suggested that expression from the intact HBA2 gene on the deleted chromosome would also be affected. Absence of HBA2 expression from the deletion chromosome was demonstrated using permissive cell hybrids and correlated with dense methylation of its promoter, whereas normally the -globin CpG islands always remain unmethylated. Further analysis showed the presence of aberrant antisense RNA transcripts originating from a truncated LUC7L gene located adjacent to the -globin cluster on the opposite strand. The 18kb deletion had removed the final three exons of the LUC7L gene, including its poly-adenylation signal, causing RNA polymerase to read through into the HBA2 promoter, leading to epigenetic silencing of the gene. The antisenseinduced promoter methylation and silencing was confined to the deletion carrying allele, indicating it involves a purely cis-acting mechanism [44] . Recently, a very similar mechanism has also been found as a cause of Lynch syndrome, a form of hereditary colorectal cancer involving germ line mutations in mismatch repair genes, in a number of Dutch and Chinese families. Tumours of the patients carried germline deletions of the final exons of the TACSTD1 gene, located directly upstream of the MSH2 mismatch repair gene [45] . The deletion was shown to cause read-through transcription of the TACSTD1 transcript into the MSH2 gene, with concomitant methylation and silencing of the MSH2 promoter allele in cis with the deletion. Interestingly, this promoter methylation shows tissue specificity and occurs only in Ep-CAM (TACSTD1) positive tissue, demonstrating a direct correlation between MSH2 silencing and transcriptional activity of the TACSTD1 gene [45] . In contrast to the HBA2/ LUC7L antisense RNA case, the read-through transcript in this case occurs on the sense strand, indicating that aberrant transcriptional read-through can lead to promoter methylation and silencing of an adjacent gene irrespective of its orientation. This is intriguing as all currently known situations of RNA induced epigenetic silencing involve sense/antisense combinations, e.g. Igf2r/air and Xist/Tsix [46, 47] . At present how the read-through transcription on the sense strand leads to promoter methylation remains unclear. However, the observation of this genetic cis-ruption mechanism resolves a controversy over the claim, based on an earlier study of one of the Chinese families, that MSH2 promoter methylation and silencing were due to heritable germline epimutation [48] .
Disruption of normal interaction between enhancer(s) and their target promoter through appearance of a new promoter
The mechanisms by which cis-acting elements seek out their target promoter(s) are currently poorly understood. The activity of insulator elements may assist in organisation of the genome into regulatory domains in which enhancers find their promoter through mechanisms such as looping, tracking or facilitated tracking [49, 50] . While promoter specificity may also play a role, the appearance of a new promoter with similar characteristics in the domain may upset the normal balance of expression. This appears to have occurred in a group of -thallasaemia patients from Melanesia [51] . Linkage to the -globin locus was confirmed but no conventional mutations or deletions in the globin coding regions or regulatory elements were found. Resequencing of a BAC containing the -globin locus derived from patient DNA identified a large number of SNPs compared to the database sequence. As described below, the issue of discerning functionally relevant SNPs from the many neutral SNPs in any genomic region is a problem that is often encountered, but which was solved here by comparing the RNA expression profiles of the locus in normal and patient erythroblasts. This revealed a major new peak of transcription in the genomic region between the regulatory elements and the globin genes in the patient sample. The peaks of transcription levels of the globin genes were concomitantly reduced. Of the seven SNPs located underlying the new transcription peak only one was unique to the patient and involved a T to C change that creates a new GATA factor binding site. Presence of GATA1, associated erythroid transcription factors, and RNA polII at the site in vivo was confirmed by chromatin immunoprecipitation. Thus, this single basepair mutation in a normally functionally neutral sequence located between the upstream regulatory elements and their cognate promoters, causes down-regulation of the -globin genes through interference with the normal regulatory mechanism [51] .
Disturbance of chromatin structure of a genome segment
The chromatin structure of a locus, usually characterized by particular epigenetic marks, has a strong influence on transcription of genes within the locus. An inappropriate chromatin structure could arise through the loss or gain of an insulator/barrier element [52] that blocks the spread of heterochromatin, or organizes the region in appropriate domains [50] . For some genes, expression output is also subject to the natural positioning of their chromosome territory within the nucleus, where the nuclear periphery is thought to exert a generally repressive influence. In general, gene-rich chromosomes tend to locate towards the centre and gene-poor chromosomes towards the edge of the nucleus [53] . Rare translocations between gene-rich and gene-poor chromosomes could cause the move of a genomic segment from a central to a peripheral nuclear location and thereby contribute to a detrimental dysregulation of potential disease genes.
A disease with a unique but enigmatic mechanism, involving epigenetic alteration of chromatin organisation at the disease locus is facioscapulohumeral dystrophy (FSHD), an autosomal dominant neuromuscular disorder affecting face and shoulder muscles.
Facioscapulohumeral dystrophy
FSHD is characterized by the deletion of an integral number of 3.3 kb tandem repeats from the subtelomeric region of the long arm of chromosome 4 [54] , and this is thought to affect expression of FSHD-associated genes through a position effect mechanism. Unaffected individuals carry between 11 and 150 copies of the repeat, named D4Z4, while patients have 10 or fewer repeats on one of their chromosomes [55] . However, loss of the complete D4Z4 array does not give rise to the disease, suggesting that the loss of repeats results in a gain-offunction mutation [56] . A highly similar repeat array is found on chromosome 10q26, but loss of repeats there is not associated with FSHD. Furthermore, the disease only occurs on only one of nine 4q allelic variants, the 4qA161 haplotype, implicating the involvement of at least one additional cis-element in the disease aetiology [57] . A number of genes or putative genes have been identified in the region centromeric to the D4Z4 repeats, ANT1, FRG1, DUX4C and FRG2, but none appear convincing candidates on their own, though DUX4C and FRG1, located 42 and 120 kb from the D4Z4 repeats, may play a role in muscle development [58] [59] [60] . Several hypotheses have been put forward to explain the disease. First, even though the D4Z4 repeat was known to contain an open reading frame (DUX4) encoding a putative homeodomain protein, no transcript had been identified in humans, despite many efforts. However, a recent comparative genomic study showed strong evolutionary conservation of the DUX4 ORF and expression of the mouse transcript [61] , and up-regulation of both DUX4 and its putative direct target PITX1 were observed in FSHD muscle tissue [62] . Processed RNA transcripts from the D4Z4 repeats producing alternative DUX4 isoforms and mi/siRNA fragments have also been suggested to play a role in pathophysiology [63] . An older mechanism involves the binding of a multiprotein repressor complex consisting of HMG2B, YY1 and nucleolin to the D4Z4 repeat [64] , negatively regulating gene expression of the 4q35 region. D4Z4 deletions remove binding sites for the repressor complex to below a certain threshold, thus allowing local decondensation of chromatin and the consequent de-repression of the genes in the region (Gabellini et al. 2002) . Also, a matrix attachment site with insulator activity, but much weaker in patients compared to controls, was found just centromeric to the repeats [65] Another study made the observation that the 4q telomere consistently localises at the nuclear periphery, unlike all other chromosome ends studied including the highly homologous 10qter [66] , and that Lamin A/C proteins are required for this process. Furthermore, D4Z4 contractions appear to be associated with hypomethylation of the remaining repeats, and D4Z4 hypomethylation is also a characteristic feature in a small number of FSHD patients without repeat contractions [67] . These observations are consistent with a recent study that identified the D4Z4 repeat as a CTCF and LaminA dependent insulator that can block both enhancer-promoter communication and the spread of repressive chromatin [68] . Insulator activity is lost upon multimerization of the repeat, possibly through methylation of the repeat and blockage of CTCF binding. Loss of repeats to below the threshold triggers hypomethylation and gain of insulator function at the residual D4Z4 repeats in FSHD patients, blocking the spread of heterochromatin from the telomere region and enabling up-regulation of the genes in the region. Despite these advances the aetiology of FSHD remains enigmatic. The loss of a chromatin boundary function may however be a plausible disease causing mechanism as exemplified by a recent report on the inactivation of the p16
INK4a tumour suppressor gene in breast cancer. While in this case the cis sequences at the boundary were unaffected, binding of CTCF and cofactors to the element was abrogated leading to destabilization of the boundary and aberrant silencing of the p16
INK4a gene [133] .
Copy number variation in the human genome
Detailed analyses on the human genome sequence through techniques such as SNP genotyping and comparative genomic hybridization have uncovered large structural variations between individual genomes [69, 70] . In addition to a large number of single nucleotide polymorphisms (SNPs), these structural variations consist of inversions and copy-number variations, sometimes of large stretches of genomic DNA. While it is now clear that copy-number variations of many DNA segments can reside in individual genomes in the population without notable deleterious effect, many other genomic loci cannot tolerate such alterations of their copy number. A type of genetic disease, closely related, but different from cis-ruption disease, is one in which the coding sequence/transcription unit of causative genes is not mutated or disrupted, but where the dosage of the intact gene is altered, and cases of this type have been termed 'genomic disorders' [71] .
Typically, disease is caused by deletion or duplication of a genomic segment containing a dosage-sensitive gene. The predominant molecular mechanism leading to this kind of disorder is non-allelic homologous recombination (NAHR) between low-copy repeats. Examples of such genomic disorders are the reciprocal 17p2 deletion/duplication pair of Charcot-MarieTooth (CMTa) and hereditary neuropathy with liability to pressure palsies (HNPP) caused by copynumber change of the dosage sensitive PMP22 gene segment flanked by two 98.7% identical low-copy repeats [73] , and Smith-Magenis syndrome (SMS) [74] and the reciprocal Potocki-Lupski syndrome [75] . As an interesting aside, SMS may also provide a revealing glimpse into the potential involvement of transvection as a mechanism that can influence disease severity. SMS (OMIM 182290) is a multiple congenital anomaly and mental retardation condition due to a heterozygous 3.7 Mb deletion on chromosome 17p11.2 in the majority of cases. Craniofacial abnormality is one of the major clinical manifestations of SMS, and includes midface hypoplasia, broad nasal bridge and prognathia. Frameshift and nonsense mutations in RAI1 (retinoic acid induced protein 1) in some patients with SMS have identified this gene as the major gene involved through haploinsuffiency.
In isogenic mouse models of SMS, differences in penetrance of craniofacial anomalies were observed between mice carrying various sized deletions around the Rai1 gene and an insertional inactivation strain which has retained the rest of the locus, suggestive of up-regulation of the wild-type copy through a trans-regulatory mechanism [76] . Genomic disorders generally involve copy-number changes of the complete gene locus involved, and therefore they are different from cis-ruption diseases. Nevertheless, copy-number variations can give rise to cis-ruption cases if it involves duplication (or deletion) of a genomic segment containing putative regulatory elements adjacent, but not including the causative gene. This has been suggested for Williams-Beuren syndrome where the chromosome 7 deletion was shown to influence the relative expression levels of genes in the flanking regions in a distance dependent manner [77] . Genome wide expression profiling in mouse tissues from different inbred strains shows that the influence of CNVs on gene expression in adjacent regions occurs on a global scale and that the effect can extend up to half a megabase [78] . An example where duplication of flanking sequences has led to disease is the case of a patient with TTP-PS (triphalangial thumb and polysyndactyly) and a 588 kb microduplication including the ZRS regulatory element, but not its target Sonic Hedgehog gene itself, which shows that an increase in copy number of a long range regulatory element can also cause a cis-ruption disorder [79, 80] . A more striking example is observed in two families with autosomal-dominant brachydactyly type A2 (BDA2), where a microduplication of a 5.5 kb fragment was detected by high-density array CGH, located approximately 110 kb downstream of the BMP2 gene. Using reporter transgenic mice the duplicated fragment was shown to harbour a limbspecific enhancer of BMP2 [81] .
Gain of inappropriate expression by translocation to new cis-regulatory environment
The creation of aberrant fusion genes as a result of chromosomal translocations is a prominent feature of many cancers, and tumour formation and growth may be caused directly by the chimeric fusion protein, but can effectively also be the result of misexpression of one part of the fusion product. However, such cases are not considered to fall within the cis-ruption effect definition, unlike situations where a translocation has brought a gene under control of a foreign enhancer [126] . A possible exception are cases where a translocation removes the complete coding region of a gene from its own promoter and fuses this coding segment to the promoter only of an unrelated gene, thereby causing the misexpression of the normal protein product. An example of this mechanism has been encountered in cases of aromatase excess syndrome, characterised by high systemic estrogen levels, short stature and pre-pubertal gynecomastia. Aromatase, encoded by the CYP19 gene, catalyses a key step in estrogen biosynthesis, and its expression is regulated by several tissue-specific promoters located some distance upstream of the coding exons. Five distinct rearrangements (inversions/deletion) have placed the full aromatase coding region under control of the promoters of five ubiquitously expressed genes, causing wide-spread up-regulation of aromatase expression [82] .
What have cis-ruption disease cases told us?
Over the past several years, it has become obvious that a proper transcriptional regulatory input/output is for most genes just as important as the intactness of their coding sequences. This has been clearly demonstrated by the specific examples described above as well as by many other cases on the fast growing list of cis-ruption diseases ( Table 1) .
The detailed study of gene loci implicated in cis-ruption diseases has led to a number of general observations. The first is the recognition that cisregulatory sequences can be located at very large distances from their linked gene. SHH and DACH enhancers have been found at distances of about 1 Mb from the gene [32, 83, 84] , while the current distance record is held by enhancers for SOX9 located at 1.3 Mb from the promoter and disrupted in Pierre Robin Sequence [28] . It will be interesting to see if that distance represents the upper distance limit or whether enhancers will be indentified at even greater distance from their target gene. Of potential relevance is the observation that the most extremely distant enhancers regulate genes that reside in relatively gene-poor regions or in gene deserts. The paucity of genes in such regions may allow large distances between enhancer and promoter to develop, while conversely it may contribute to its persistence by selecting against insertion of any genomic features, such as another promoter. Second, while indeed in some cases long-range enhancers are found in gene deserts around their target gene (e.g. DACH [84] , SOX9 [28] ), more often they reside beyond or within the introns of neighbouring genes (e.g. PAX6, SHH [21, 32] ). In those situations the surrounding genes, although closer to the enhancer than the real target gene, either do not significantly respond to the enhancer [21] , potentially due to enhancer-promoter specificity or with the aid of other elements creating a distinct localization bias [85] or providing a tethering function [131, 132] . Alternatively the response of the adjacent gene to the enhancer has no functional consequence in itself, even though the presence of an additional responsive promoter may have an influence on the strength of transcription from the true target promoter (e.g. Lunapark, Evx2 and HoxD in limb expression [87] ; growth hormone and CD79b genes [88] , and the deletion of such 'bystander' promoter, i.e. a non-intended, but receptive promoter of an adjacent gene, may cause unwanted up-regulation of the target gene. Endogenous situations of enhancer sharing are not uncommon (e.g. in the Hox [86, 89] and Irx gene clusters [90] ), but when artificially created through translocation, transgene integration or a promoter creating mutation they can lead to disease. [51, 33, 87] .
Third, it has become clear from the study of cisruption diseases that the main class of genes associated with it is the group encoding developmental regulators and signalling factors (Table 1) . This overrepresentation of these genes may be due to several reasons: the extended regulatory landscape of developmental control genes reflects their need for sophisticated expression profiles to accomplish multiple roles in various spatio-temporal defined sites in the embryo. Consistent with this, bioinformatic analysis of multi-species conserved elements in a genomewide manner has revealed that many of the highly conserved elements cluster near genes with key developmental functions [91] . Furthermore, correct quantitative levels are often of key importance for the functional output of many developmental regulators. Thus, the size of their regulatory domain, its modular structure and the dosage sensitivity of many of these genes all contribute to these genes being a prime substrate for cis-ruption disease mechanisms. Nonetheless it is likely that in future many other genes, in particular if sharing some of the above characteristics and/or associated with a strong phenotypic presentation, may be linked to disorders through a cis-ruption mechanism.
Since regulatory mutations are likely to disrupt only a spatio-temporally specific subset of the normal expression pattern, the clinical phenotype observed in a patient with a cis-ruption disorder can be different from that due to a complete loss of the underlying gene, as seen in the case of the SOX9 gene. Intragenic mutation or translocations 'near' the gene causes campomelic dysplasia [83] , while loss or mutation of very long-range enhancers is associated with Pierre Robin Sequence, a much milder disease that affects mainly the jaw and palate [51] . The variety in disease phenotypes associated with different mechanisms of SHH inactivation is even more instructive: loss of activity in the developing embryonic midline through intragenic mutation, translocations removing brain enhancers or a point mutation in a brain enhancer all result in holoprosencephaly [30, 31, 29] . Complete removal of the more distal limb-specific ZRS enhancer shows similarity to the severe limb truncating malformation acheiropodia (OMIM 200500), while a duplication including the ZRS was found in patients with triphalangial thumb and polysyndactyly (TPTPS; OMIM 190605) [79, 80] . Finally, point mutations in the ZRS give rise to pre-axial polydactyly (PPD) [36] [37] [38] . Thus, different regulatory mutations can have different phenotypic manifestations from each other and from intragenic loss-of-function mutations, making it likely that many clinical phenotypes may be unexpectedly linked to genes that were not considered as they are well known for another disease.
Regulatory variation: from cis-ruption disease to common disease susceptibility to morphological evolution
In the mechanisms and cases described above disruption of cis-regulation has had a dramatic and deleterious effect on transcription of the target gene, leading to disease, but in many situations the mutation and its effect will be more subtle. Polymorphic variation (so called rather than mutation) in cisregulatory elements between individuals in or between populations forms a major factor in specific traits as well as in common genetic disease. A large percentage of quantitative traits are caused by expression QTLs, variants that affect the level of gene expression, but identification of the functionally relevant regulatory polymorphisms among the sea of polymorphisms found all over the genome is a daunting task [92] . However, the success of wholegenome association studies in recent years has greatly accelerated the process. A glance at the emerging GWAS literature suggests that a significant portion of associated SNPs fall in non-coding regions of the genome [93] .
A well-established example is the monogenic trait of lactose tolerance in adult life, where several independently arisen SNPs in a cis-element 14 kb upstream of the LCT gene are associated with persistence of lactase expression [94, 95] . Eye pigmentation is one of the most visible human phenotypic traits, with a high level of heritability and a spectrum of variation, mostly among individuals with European ancestry. A SNP in a cis-regulatory element for the OCA2 (oculocutaneous albinism 2) gene is thought to be the cause of blue eye colour in all humans. The cis-element is located 21 kb upstream from the OCA2 promoter in a conserved region in an intron of the neighbouring HERC2 gene. The functional effects of the SNP are less clear and both positive and negative functions have been suggested [96, 97] . Homozygosity for a single blue haplotype is perfectly associated with blue eyes in individuals from Denmark, Turkey and Jordan, suggesting a common founder mutation [96] .
Furthermore, the highly modular cis-regulatory landscape of many developmental regulatory genes allows changes in protein functioning in restricted expression sites only, while avoiding the pleiotropic effects of a coding region mutation or deletion. Cis-regulatory variation is now recognized as an important contributing factor in the evolution of traits and ultimately species [98, 99] . The list of examples of evolution through regulatory divergence is growing rapidly. A recent example is the case of a deeply conserved cis-element showing rapid evolution specifically in the human lineage which was shown to have gained a domain of strong enhancer activity in the limb in comparison to its chimpanzee and rhesus orthologues, leading to speculation that it may have contributed to unique aspects of human limb patterning [100] .
CONCLUSIONS
Over the last half century, it has become well established that our genome carries the code to transform genetic information into the amino acid sequence of our proteins. The information that determines which, when, where and how much of those proteins to produce is also encoded in the genome, and even though the discovery of regulatory mechanisms is gaining pace, our understanding of that code is still elementary. Detailed analysis of human genetic malformations has provided invaluable information, firstly in highlighting the occurrence and scope of long-distance transcriptional regulation in the genome, and secondly in the elucidation of a number of different mechanisms of longrange gene control. Whereas some changes in cisregulatory elements through deletion or mutation clearly have dramatic effects leading to genetic disease, other changes may have more subtle effects and are likely to contribute to differences between individuals, and on a longer timescale may contribute to evolutionary divergence.
The continued study of new cis-ruption disease cases keeps adding to the amazing plethora of regulatory mechanisms embedded in our genome. A better understanding of the regulatory code and the mechanisms that translate that information into spatiotemporal and quantitatively correct gene expression and moreover how variations or mutations in cis-elements change the read-out of this code will be a necessary and interesting step towards improved disease management and treatment.
Key Points
Genetic disease can be caused by coding region mutation/ deletion as well as by interference with normal gene expression through disruption of its cis-regulatory control. To describe disease cases caused by the latter mechanism the new term of 'cis-ruption disease' is introduced as a new, concise generic name. Disruption of cis-regulation leading to disease can occur via several distinct mechanisms that can be divided into a number of separate categories. The cis-regulatory landscape of genes, in particular developmental regulators, can be very large and may extend into or beyond adjacent genes.
